|
Q2 2022
Filed on Aug 15, 2022
|
402,200
|
$13.27 - $25.5
$5.34M - $10.3M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
100,000
|
$16.57 - $35.1
$1.66M - $3.51M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
3,280,000
|
N/A
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
346,524
|
$1.15 - $3.34
$399K - $1.16M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
90,045
|
$29.86 - $62.36
$2.69M - $5.62M
|
|
|
Q1 2022
Filed on May 16, 2022
|
270,698
|
N/A
|
|
|
Q1 2022
Filed on May 16, 2022
|
900,000
|
$9.74 - $17.92
$8.77M - $16.1M
|
|
|
Q1 2022
Filed on May 16, 2022
|
600,000
|
$6.0 - $16.98
$3.6M - $10.2M
|
|
|
Q1 2022
Filed on May 16, 2022
|
50,000
|
$14.54 - $21.5
$727K - $1.08M
|
|
|
Q1 2022
Filed on May 16, 2022
|
200,000
|
$2.46 - $5.92
$492K - $1.18M
|
|
|
Q1 2022
Filed on May 16, 2022
|
149,200
|
$3.12 - $8.17
$466K - $1.22M
|
|
|
Q1 2022
Filed on May 16, 2022
|
521,257
|
$2.08 - $12.2
$1.08M - $6.36M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
300,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
400,000
|
$4.65 - $7.23
$1.86M - $2.89M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
350,000
|
$24.34 - $31.17
$8.52M - $10.9M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
300,000
|
$14.31 - $23.87
$4.29M - $7.16M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
200,000
|
$45.28 - $74.5
$9.06M - $14.9M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
800,000
|
$5.89 - $9.73
$4.71M - $7.78M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
478,200
|
$4.43 - $8.33
$2.12M - $3.98M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
144,439
|
$7.7 - $37.13
$1.11M - $5.36M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
4,807,557
|
$2.92 - $5.74
$14M - $27.6M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
1,000,000
|
$1.89 - $3.12
$1.89M - $3.12M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
48,132
|
$207.57 - $280.17
$9.99M - $13.5M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
950,000
|
$5.67 - $8.54
$5.39M - $8.11M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
100,000
|
$25.61 - $110.96
$2.56M - $11.1M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
150,000
|
$94.25 - $115.99
$14.1M - $17.4M
|
|
Minerva Neurosciences Inc
|
Q4 2021
Filed on Feb 14, 2022
|
95,744
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
479,506
|
$4.58 - $8.34
$2.2M - $4M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
3,000,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
800,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
300,000
|
$6.77 - $14.41
$2.03M - $4.32M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
53,455
|
$105.0 - $178.37
$5.61M - $9.53M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
500,000
|
$109.72 - $129.16
$54.9M - $64.6M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
750,000
|
$73.87 - $92.86
$55.4M - $69.6M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
427,975
|
$3.56 - $4.64
$1.52M - $1.99M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
354,495
|
$35.91 - $50.5
$12.7M - $17.9M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
175,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
600,000
|
$5.93 - $17.83
$3.56M - $10.7M
|
|
Cerevel Therapeutics Hldng I
|
Q3 2021
Filed on Nov 15, 2021
|
19,316
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
239,099
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
83,332
|
N/A
|
|
Catabasis Pharmaceuticals In
|
Q3 2021
Filed on Nov 15, 2021
|
3,550,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
545,320
|
$29.99 - $39.13
$16.4M - $21.3M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
400,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
132,867
|
$11.55 - $20.3
$1.53M - $2.7M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
363,766
|
$25.71 - $35.24
$9.35M - $12.8M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
185,000
|
$95.64 - $131.48
$17.7M - $24.3M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
240,000
|
$9.74 - $10.05
$2.34M - $2.41M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
893,500
|
$5.12 - $6.89
$4.57M - $6.16M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
284,988
|
$6.68 - $9.1
$1.9M - $2.59M
|
|